| 1 | LY9
|
| Targeting of Ly9 (CD229) Disrupts Marginal Zone and B1 B Cell Homeostasis and Antibody Responses.
|
| Cuenca M, Romero X, Sintes J, Terhorst C, Engel P.
|
| J Immunol 196(2):726-37. doi: 10.4049/jimmunol.1501266. Epub 2015 Dec 14.
2016
|
| 2 | LY9
|
| The expression of the hepatocyte SLAMF3 (CD229) receptor enhances the hepatitis C virus infection.
|
| Cartier F, Marcq I, Douam F, Ossart C, Regnier A, Debuysscher V, Lavillette D, Bouhlal H.
|
| PLoS One 9(6):e99601. doi: 10.1371/journal.pone.0099601. eCollection 2014.
2014
|
| 3 | LY9
|
| Ly9 (CD229) Cell-Surface Receptor is Crucial for the Development of Spontaneous Autoantibody Production to Nuclear Antigens.
|
| de Salort J, Cuenca M, Terhorst C, Engel P, Romero X.
|
| Front Immunol 4:225. doi: 10.3389/fimmu.2013.00225. eCollection 2013.
2013
|
| 4 | CD244, LY9, SLAMF1
|
| SLAM family markers resolve functionally distinct subpopulations of hematopoietic stem cells and multipotent progenitors.
|
| Oguro H, Ding L, Morrison SJ.
|
| Cell Stem Cell 13(1):102-16. doi: 10.1016/j.stem.2013.05.014.
2013
|
| 5 | LY9
|
| Cutting edge: Ly9 (CD229), a SLAM family receptor, negatively regulates the development of thymic innate memory-like CD8+ T and invariant NKT cells.
|
| Sintes J, Cuenca M, Romero X, Bastos R, Terhorst C, Angulo A, Engel P.
|
| J Immunol 190(1):21-6. doi: 10.4049/jimmunol.1202435. Epub 2012 Dec 7.
2013
|
| 6 | LY9
|
| Identification of SLAMF3 (CD229) as an inhibitor of hepatocellular carcinoma cell proliferation and tumour progression.
|
| Marcq I, Nyga R, Cartier F, Amrathlal RS, Ossart C, Ouled-Haddou H, Ghamlouch H, Galmiche A, Chatelain D, Lamotte L, Debuysscher V, Fuentes V, Nguyen-Khac E, Regimbeau JM, Marolleau JP, Latour S, Bouhlal H.
|
| PLoS One 8(12):e82918. doi: 10.1371/journal.pone.0082918. eCollection 2013.
2013
|
| 7 | LY9, SLAMF6
|
| Increased expression of SLAM receptors SLAMF3 and SLAMF6 in systemic lupus erythematosus T lymphocytes promotes Th17 differentiation.
|
| Chatterjee M, Rauen T, Kis-Toth K, Kyttaris VC, Hedrich CM, Terhorst C, Tsokos GC.
|
| J Immunol 188(3):1206-12. doi: 10.4049/jimmunol.1102773. Epub 2011 Dec 19.
2012
|
| 8 | IL17A, LY9, RORC, SLAMF6
|
| CD3-T cell receptor co-stimulation through SLAMF3 and SLAMF6 receptors enhances RORγt recruitment to the IL17A promoter in human T lymphocytes.
|
| Chatterjee M, Hedrich CM, Rauen T, Ioannidis C, Terhorst C, Tsokos GC.
|
| J Biol Chem 287(45):38168-77. doi: 10.1074/jbc.M112.415067. Epub 2012 Sep 18.
2012
|
| 9 | CD244, CD48, CD84, LY9, SLAMF1, SLAMF6, SLAMF7
|
| Expression of SLAM (CD150) cell-surface receptors on human B-cell subsets: from pro-B to plasma cells.
|
| De Salort J, Sintes J, Llinàs L, Matesanz-Isabel J, Engel P.
|
| Immunol Lett 134(2):129-36. doi: 10.1016/j.imlet.2010.09.021. Epub 2010 Oct 7.
2011
|
| 10 | CD48, LY9, SLAMF1, SLAMF7
|
| Differential expression of SLAMS and other modulatory molecules by human plasma cells during normal maturation.
|
| Rodríguez-Bayona B, Ramos-Amaya A, Brieva JA.
|
| Immunol Lett 134(2):122-8. doi: 10.1016/j.imlet.2010.09.015. Epub 2010 Oct 13.
2011
|
| 11 | CD244, CD48, CD84, LY9, SLAMF1, SLAMF6, SLAMF7, SLAMF8, SLAMF9
|
| SLAM family receptors and the SLAM-associated protein (SAP) modulate T cell functions.
|
| Detre C, Keszei M, Romero X, Tsokos GC, Terhorst C.
|
| Semin Immunopathol 32(2):157-71. Epub 2010 Feb 10.PMID: 20146065 2010
|
| 12 | CD244, CD48, CD84, LY9, SLAMF1, SLAMF6, SLAMF7, SLAMF8, SLAMF9
|
| The SLAM and SAP gene families control innate and adaptive immune responses.
|
| Calpe S, Wang N, Romero X, Berger SB, Lanyi A, Engel P, Terhorst C.
|
| Adv Immunol 97:177-250. Review.PMID: 18501771 2008
|
| 13 | LY9
|
| Association of LY9 in UK and Canadian SLE families.
|
| Cunninghame Graham DS, Vyse TJ, Fortin PR, Montpetit A, Cai YC, Lim S, McKenzie T, Farwell L, Rhodes B, Chad L, Hudson TJ, Sharpe A, Terhorst C, Greenwood CM, Wither J, Rioux JD; CaNIOS GenES Investigators.
|
| Genes Immun 9(2):93-102. doi: 10.1038/sj.gene.6364453. Epub 2008 Jan 24.
2008
|
| 14 | LY9
|
| Characterization of mouse CD229 (Ly9), a leukocyte cell surface molecule of the CD150 (SLAM) family.
|
| Sintes J, Vidal-Laliena M, Romero X, Tovar V, Engel P.
|
| Tissue Antigens 70(5):355-62.
2007
|
| 15 | LY9
|
| CD229 (Ly9) lymphocyte cell surface receptor interacts homophilically through its N-terminal domain and relocalizes to the immunological synapse.
|
| Romero X, Zapater N, Calvo M, Kalko SG, de la Fuente MA, Tovar V, Ockeloen C, Pizcueta P, Engel P.
|
| J Immunol 174(11):7033-42.
2005
|
| 16 | LY9
|
| The cell surface expression of SAP-binding receptor CD229 is regulated via its interaction with clathrin-associated adaptor complex 2 (AP-2).
|
| Del Valle JM, Engel P, Martín M.
|
| J Biol Chem 278(19):17430-7. Epub 2003 Mar 5.
2003
|
| 17 | LY9
|
| Molecular characterization and expression of a novel human leukocyte cell-surface marker homologous to mouse Ly-9.
|
| de la Fuente MA, Tovar V, Villamor N, Zapater N, Pizcueta P, Campo E, Bosch J, Engel P.
|
| Blood 97(11):3513-20. 2001
|
| 18 | LY9, CD48
|
| Physical and genetic linkage of the genes encoding ly-9 and CD48 on mouse and human chromosomes 1.
|
| Kingsmore SF, et al.
|
| Immunogenetics 42 : 59-62. 1995
|
| 19 | LY9
|
| Isolation and characterization of cDNA clones for mouse Ly-9.
|
| Sandrin MS, et al.
|
| J Immunol 149 : 1636-1641. 1992
|